Exegenesis Bio
Philadelphia, United States · Founded 2019 · $80.0M raised
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2019
- Business Model
- B2B
- Website
- exegenesisbio.com
- Total Funding
- $80.0M
- Last Round
- $50.0M Extension RoundJun 2021
- Rounds
- 3
About
Leading domestic gene therapy company
Summary
Exegenesis Bio is a Biotech company based in Philadelphia, United States, founded in 2019. It has raised $80.0M in total across 3 rounds, most recently a $50.0M Extension Round round in Jun 2021. Investors include Legend Capital, Hillhouse Capital and K2 Venture Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...